文献速递中毒与环境急症儿科与产科急症重症综合管理与镇静镇痛

美国中心有无儿科肾脏科医师对儿童中毒体外治疗的影响比较

Comparison of children receiving extracorporeal treatments for poisoning at United States centers with and without a pediatric nephrologist.
PubMed 文献 · Clin Toxicol (Phila) · 2025-02-06
一句话结论回顾性队列提示,青少年中毒体外治疗由成人肾脏科医师实施时均用间歇性血液透析,死亡率与有儿科肾脏科医师的中心无差异(P=0.1)。

该回顾性队列研究纳入2000—2024年美国中西部三州毒物中心报告的≤17岁接受体外治疗的中毒患儿72例。54例在有儿科肾脏科医师的医院治疗,18例(14—17岁,最低体重35 kg)在仅由成人肾脏科医师值守的医院治疗。成人肾脏科组全部接受间歇性血液透析(18/18,100%),儿科肾脏科组为57%(31/54,P<0.001);儿科肾脏科组更常用连续性肾脏替代治疗(28/54,52% vs 0/18,P<0.05)。两组死亡率无差异(9/54,17% vs 0/18,P=0.1)。作者认为成人肾脏科医师可为青少年中毒成功实施体外治疗。

要点

  • ≤17岁中毒体外治疗患儿共72例:54例在有儿科肾脏科医师的医院,18例(14—17岁,最低体重35 kg)在仅成人肾脏科医师值守的医院。
  • 成人肾脏科组全部接受间歇性血液透析(18/18,100%),儿科肾脏科组为57%(31/54,P<0.001)。
  • 儿科肾脏科组更常用连续性肾脏替代治疗(28/54,52% vs 0/18,P<0.05)。
  • 两组死亡率无差异:儿科肾脏科组9/54(17%) vs 成人肾脏科组0/18(P=0.1)。
  • 成人肾脏科组最常见毒物为有毒醇类(10/18,55%)和水杨酸盐(4/18,22%)。

适用人群与场景

  • 2000—2024年美国中西部三州毒物中心报告的、年龄≤17岁、因中毒接受体外治疗的全部患儿。
  • 成人肾脏科医师治疗组为14—17岁、最低体重35 kg的青少年。

处置流程与药物剂量

  • 在仅由成人肾脏科医师值守的医院,18例青少年均接受间歇性血液透析(18/18,100%)。
  • 在有儿科肾脏科医师的医院,54例中31例(57%)接受间歇性血液透析,28例(52%)接受连续性肾脏替代治疗。

研究设计与关键结果

  • 回顾性队列研究,纳入72例≤17岁中毒体外治疗患儿:54例在有儿科肾脏科医师的医院治疗,18例(14—17岁,最低体重35 kg)在仅由成人肾脏科医师值守的医院治疗。
  • 成人肾脏科组最常见毒物为有毒醇类(10/18,55%)和水杨酸盐(4/18,22%)。
  • 成人肾脏科组更常用间歇性血液透析:18/18(100%) vs 儿科肾脏科组31/54(57%),P<0.001。
  • 儿科肾脏科组更常用连续性肾脏替代治疗:28/54(52%) vs 成人肾脏科组0/18,P<0.05。
  • 两组死亡率无差异:儿科肾脏科组9/54(17%) vs 成人肾脏科组0/18,P=0.1。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,成人肾脏科医师可为青少年(14—17岁,最低体重35 kg)中毒成功实施体外治疗。
  • 本研究提示,在仅有成人肾脏科医师的中心,青少年中毒体外治疗以间歇性血液透析为主,其死亡率与有儿科肾脏科医师的中心无差异(P=0.1)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pediatric nephrologists are rare in the United States; many children with poisoning needing extracorporeal treatments may not have timely access to care. This study compared outcomes in children receiving extracorporeal treatments for poisoning at centers with and without a pediatric nephrologist.

METHODS: This was a retrospective cohort study of all patients aged ≤17 years reported to an American poison center covering three upper midwestern states during 2000-2024.

RESULTS: We identified 72 patients: 54 received extracorporeal treatments at a hospital with pediatric nephrologists, and 18 patients aged 14-17 years (minimum weight, 35 kg) received extracorporeal treatments at hospitals staffed solely by adult nephrologists. The most common responsible poisons were toxic alcohols (10/18, 55%) and salicylates (4/18, 22%). Children receiving extracorporeal treatments from adult nephrologists more commonly (P <0.001) received intermittent hemodialysis (18/18, 100%) compared to pediatric nephrologists (31/54, 57%). Conversely, children treated by pediatric nephrologists more commonly (P <0.05) received continuous kidney replacement therapy (28/54, 52%) compared to adult nephrologists (0/18). We found no difference (P = 0.1) in mortality between the children treated by pediatric nephrologists (9/54, 17%) compared to those treated by adult nephrologists (0/18).

DISCUSSION: Teenage children commonly received hemodialysis from adult nephrologists for poisoning and had similar outcomes to those treated by pediatric nephrologists.

CONCLUSIONS: These data suggest adult nephrologists can successfully perform extracorporeal treatments for poisoning in teenage children.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Cole JB, Kouri AM, King JD, et al. Comparison of children receiving extracorporeal treatments for poisoning at United States centers with and without a pediatric nephrologist. Clin Toxicol (Phila). 2025. PMID: 39911112. doi:10.1080/15563650.2025.2456109

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。